Characterization study demonstrating that golden hamster and ferret FcαR can bind human IgA with high affinity, supporting their use as animal models for human IgA-mediated immunity, though without clinical efficacy or safety data.
Randomized controlled trial with pre-specified primary endpoints (antibody and T-cell responses) in a well-defined older adult population shows statistically significant morning vaccination advantage, though T-cell effect did not reach significance.
Rigorous prospective cohort study with well-designed immunological methodology comparing autoantibody profiles across three groups; identifies a clear protective effect of vaccination against infection-induced autoimmunity with adequate sample sizes and controlled analysis.
A sound preclinical study in murine cold tumor models showing mechanistic evidence of enhanced neoantigen-specific T cell immunity and tumor control, but limited to in vivo animal work without human clinical data.
A rigorous preclinical immunology study with sound design and clear mechanistic findings on vaccine-induced immune responses, but limited to mouse models without clinical efficacy data in humans.
A controlled preclinical study demonstrating synergy between mRNA-LNP vaccination and 4-1BB costimulation in a single tumor model, with mechanistic insight but limited to mouse melanoma.
Mechanistic integration of in vitro and in vivo metabolomics in newborns reveals distinct BCG-induced metabolic signatures that may explain trained immunity, but lacks quantified effect sizes, clinical endpoints, or comparative statistical contrasts.
A controlled animal study of sound design showing clinical benefit (reduced diarrhea, improved growth) and coordinated immune responses, but limited by single-species testing, surrogate endpoints, and absence of efficacy statistics for the primary comparisons.